| PACLX | RPBAX | PACLX / RPBAX | |
| Total Expense Ratio | 0.98 | 0.61 | 161% |
| Annual Report Gross Expense Ratio | 1.01 | 0.66 | 153% |
| Fund Existence | 22 years | 87 years | - |
| Gain YTD | 6.499 | 6.244 | 104% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 2500 | 100% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 70.4B | 5.27B | 1,336% |
| Annual Yield % from dividends | 1.48 | 2.02 | 73% |
| Returns for 1 year | 2.63 | 8.37 | 31% |
| Returns for 3 years | 18.73 | 28.34 | 66% |
| Returns for 5 years | 6.11 | 10.81 | 57% |
| Returns for 10 years | 59.74 | 60.34 | 99% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| ICTTX | 17.54 | 0.25 | +1.45% |
| ICON Health and Information Tech Inv | |||
| KLCCX | 8.10 | 0.10 | +1.25% |
| Federated Hermes Kaufmann Large Cap C | |||
| JHTCX | 21.38 | 0.11 | +0.52% |
| JPMorgan Hedged Equity 3 C | |||
| MPGVX | 17.76 | 0.07 | +0.40% |
| Mondrian Global Equity Value | |||
| JVMSX | 31.13 | 0.02 | +0.06% |
| JHancock Disciplined Value Mid Cap R2 | |||